 |
In Today's Vidyya
 Reducing exposure to allergens in the classroom.
|
|
 |
FDA Approves First NDA For Levothyroxine Sodium
The FDA approved the first NDA for the thyroid hormone replacement drug, levothyroxine sodium (Unithroid) for use in adults and children. More...
|
|
 |
Study Launched To Test Public Access Defibrillation
Can community volunteers be as effectively trained as emergency medical personnel in the use of automatic external defibrillators (AEDs), devices that shock a stopped heart back into beating? To answer this question, the National Heart, Lung, and Blood Institute has funded a large multi-center study to test the life-saving potential and cost effectiveness of public access defibrillation (PAD).
More...
|
|
 |
NIH Consensus Development Conference Reaffirms Single Course Of Antenatal Corticosteroids For Preterm Women
A consensus panel convened by the National Institutes of Health has reaffirmed the importance of single-course treatment with corticosteroids for pregnant women at risk for pre-term delivery. However, the panel concluded that current data do not support the routine use of repeat courses of this treatment. More...
|
|
 |
Draft Statement - Antenatal Corticosteroids Revisited: Repeat Courses
The NIH organized this conference to present research on repeat courses of antenatal corticosteroid therapy. After a day of presentations and audience discussion, an independent, non-Federal consensus development panel weighed the scientific evidence and wrote a draft statement that was presented to the audience on the second day. Interested professionals can read that statement in today's issue. More...
|
|
 |
AAAAI: Children With Asthma And Allergies Need To Take Special Precautions At School
A new survey by the American Academy of
Allergy, Asthma and Immunology (AAAAI) of allergists, immunologists and school
nurses showed that children with asthma and allergies often have reactions to
triggers in the classroom. More...
|
|